Albert Matalon, MD

  • Specialty: Nephrology
  • Languages: English, Hebrew
  • Phone: 212-263-7239

About Me

Conditions and Treatments

kidney stones, primary care, adult polycystic kidney disease, kidney transplant, glomerulonephritis, kidney disease, polycystic kidney diseases, glomerular disease, high blood pressure disorder, peritoneal dialysis, kidney failure, hemodialysis
Show More Conditions

Credentials

Positions
  • Clinical Assistant Professor, Department of Medicine
Board Certifications
  • American Board of Internal Medicine (Nephrology), 2001
  • American Board of Internal Medicine - Internal Medicine, 1998
Education and Training
  • Fellowship, Columbia Presbysterian Medical Center, Nephrology, 2000
  • Residency, Long Island Jewish Medical Center, Internal Medicine, 1998
  • MD from New York University, 1995
Departments

Is this your profile?

Edit profile

Is this your profile?

Edit profile

Locations and Appointments

View Insurance Plans Accepted
  • Aetna
    • Aetna HMO
    • Aetna Indemnity
    • Aetna Medicare
    • Aetna POS
    • Aetna PPO/EPO
  • Empire Blue Cross Blue Shield
    • Empire Blue Cross Blue Shield EPO
    • Empire Blue Cross Blue Shield HMO
    • Empire Blue Cross Blue Shield Indemnity
    • Empire Blue Cross Blue Shield MediBlue
    • Empire Blue Cross Blue Shield POS
    • Empire Blue Cross Blue Shield PPO
    • Empire Blue Cross Blue Shield Pathways, Enhanced
Albert Matalon, M.D.

530 1st Avenue, Suite 4A
New York, NY 10016

Albert Matalon, M.D.

317 East 34th Street, 12th Floor
New York, NY 10016

Research My Research

Interests

dialysis, treament of anemia, prevention of dialysis-related infection, familial dysautonomia, Fabry disease

Research Interests Timeline

These focus areas and their associated publications are derived from PubMed and the MeSH term library.
represents one publication
Loading...

Publications

  • Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease

    Nazzal, Lama; Roberts, Julia; Singh, Prabhjot; Jhawar, Sachin; Matalon, Albert; Gao, Zhan; Holzman, Robert; Liebes, Len; Blaser, Martin J; Lowenstein, Jerome Nazzal, Lama; Roberts, Julia; Singh, Prabhjot; Jhawar, Sachin; Matalon, Albert; Gao, Zhan; Holzman, Robert; Liebes, Len; Blaser, Martin J; Lowenstein, Jerome
    Nephrology, dialysis, transplantation. 2017 Mar 31. ?-?

  • Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study

    Fattom, Ali; Matalon, Albert; Buerkert, John; Taylor, Kimberly; Damaso, Silvia; Boutriau, Dominique Fattom, Ali; Matalon, Albert; Buerkert, John; Taylor, Kimberly; Damaso, Silvia; Boutriau, Dominique
    Human vaccines & immunotherapeutics. 2015. 11 (3): 632-641

  • Conversion to lanthanum carbonate monotherapy effectively controls serum phosphorus with a reduced tablet burden: a multicenter open-label study

    Vemuri, Nirupama; Michelis, Michael F; Matalon, Albert Vemuri, Nirupama; Michelis, Michael F; Matalon, Albert
    BMC nephrology. 2011 Sep 30. 12: 49-49

Read All Publications (17)